Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;71(3):229-234.
doi: 10.1111/lam.13334. Epub 2020 Jul 16.

Probiotics and COVID-19: is there any link?

A Akour  1   2
Affiliations
Review

Probiotics and COVID-19: is there any link?

A Akour. Lett Appl Microbiol. 2020 Sep.

Abstract

Understanding mechanisms of the novel SARS-CoV2 infection and progression can provide potential novel targets for prevention and/or treatment. This could be achieved via the inhibition of viral entry and/or replication, or by suppression of the immunologic response that is provoked by the infection (known as the cytokine storm). Probiotics are defined as 'live microorganisms that, when administered in adequate amounts, confer a health benefit on the host'. There is scarcity of evidence about the relationship between COVID-19 and gut microbiota. So, whether or not these supplements can prevent or ameliorate COVID-19-associated symptoms is not fully understood. The aim of this study is to provide an indirect evidence about the utility of probiotics in combating COVID-19 or its associated symptoms, through the review of its antiviral and anti-inflammatory properties in vitro, animal models and human trials. SIGNIFICANCE AND IMPACT OF THE STUDY: The role of probiotics in alleviation of the novel COVID-19 has not been established. This review provides an insight about the anti-inflammatory, antiviral effects of probiotics in vitro, animal models and human. The latter can provide an indirect evidence and/or hypothesis-driven approach to investigate the use of probiotics as adjunctive therapy in the prophylaxis and/or alleviation of COVID-19 symptoms.

Keywords: COVID-19; adjunctive therapy; anti-inflammatory; antiviral; microbiota; probiotics.

PubMed Disclaimer

References

    1. Ayyanna,R., Ankaiah,D. and Arul,V. (2018) Anti‐inflammatory and antioxidant properties of probiotic bacterium Lactobacillus mucosae AN1 and Lactobacillus fermentum SNR1 in Wistar Albino Rats. Front Microbiol 9, 10.3389/fmicb.2018.03063. - DOI - PMC - PubMed
    1. Barros,C.P., Guimarães,J.T., Esmerino,E.A., Duarte,M.C.K.H., Silva,M.C., Silva,R., Ferreira,B.M. and Sant'Ana,A.S. et al. (2020) Paraprobiotics and postbiotics: concepts and potential applications in dairy products. Curr Opin Food Sci 32, 1–8.
    1. Baud,D., Agri,V.D., Gibson,G.R., Reid,G. and Giannoni,E. (2020) Using probiotics to flatten the curve of coronavirus disease COVID‐2019 pandemic. Front. in Public Health 8, 186. - PMC - PubMed
    1. Cao,Y.C., Deng,Q.X. and Dai,S.X. (2020) Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID‐ 19: an evaluation of the evidence. Travel Med Infect Dis 10.1016/j.tmaid.2020.101647. - DOI - PMC - PubMed
    1. De Almada,C.N., Nunes De Almada,C., Martinez,R.C. and Sant'ana Ade,S. (2015) Characterization of the intestinal microbiota and its interaction with probiotics and health impacts. Appl Microbiol Biotechnol 99, 4175–4199. - PubMed